| 000 | 01565 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517194603.0 | ||
| 264 | 0 | _c20180820 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2018.01.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Hua-Li | |
| 245 | 0 | 0 |
_aSecretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMar 2018 |
||
| 300 |
_a13-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCatalase _xmetabolism |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 |
_aHypertrophy _xdrug therapy |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNeuropeptides _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSecretogranin II _xpharmacology |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 700 | 1 | _aLiu, Yan | |
| 700 | 1 | _aJiang, Wei | |
| 700 | 1 | _aWang, Xiao-Xiao | |
| 700 | 1 | _aYuan, Guo-Lin | |
| 700 | 1 | _aZhao, Yi-Lin | |
| 700 | 1 | _aYu, Chao | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 822 _gp. 13-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2018.01.008 _zAvailable from publisher's website |
| 999 |
_c27983120 _d27983120 |
||